Anlon Healthcare Quarterly Results for Trading Insights
AHCL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹21 Cr
QMarch 2025
Anlon Healthcare Quarterly Results Key Highlights
- Revenue of ₹121 Cr in March 2025 (+0.0% vs March 2025, +80.6% vs March 2024)
- Net Profit of ₹21 Cr in March 2025 (+0.0% vs March 2025, +110.0% vs March 2024)
- EBITDA of ₹32 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 27.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹6.37 in March 2025 (+0.0% vs March 2025)
Anlon Healthcare Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 170 | 121 | 67 | 113 | 58 | 40.5% | - |
| Net Profit (₹ Cr) | 35 | 21 | 10 | 6 | 0 | - | - |
| EBITDA (₹ Cr) | 50 | 32 | 16 | 13 | 6 | - | - |
| EPS (₹) | 8.40 | 6.37 | 6.68 | 4.85 | -0.09 | - | - |
| Operating Margin (%) | 29.0% | 27.0% | 23.0% | 11.0% | 9.0% | - | - |
Anlon Healthcare Share Price Trend Around Quarterly Results
Visualize Anlon Healthcare's 1-year price movement across quarterly results — ideal for logging trades in Anlon Healthcare share price
chart using Tickjournal. All values in ₹.
Related Pages for Anlon Healthcare
Additional stock information and data for AHCL
Revenue Trend (₹ Cr)
March 2023
113
March 2024
67
March 2025
121
2026
170
Net Profit Trend (₹ Cr)
March 2023
6
March 2024
10
March 2025
21
2026
35
Operating Margin Trend (%)
March 2023
11.0%
March 2024
23.0%
March 2025
27.0%
2026
29.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Anlon Healthcare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores